Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Liver Diseases Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00143000
What this trial is testing

Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3

Who this might be right for
Hepatitis C Virus
NORDynamIC Study Group 392
Large-scale testing (Phase 3)Looking for participantsNCT06493799
What this trial is testing

In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop

Who this might be right for
Chronic Liver Disease
Green Cross Wellbeing 226
Early research (Phase 1)Study completedNCT00782353
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 35
Not applicableStudy completedNCT04094272
What this trial is testing

Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

Who this might be right for
Pulmonary Artery HypertensionChronic Hepatitis c
Kantonsspital Olten 49
Early research (Phase 1)UnknownNCT00300807
What this trial is testing

Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
XTL Biopharmaceuticals 36
Not applicableNot Yet RecruitingNCT06808009
What this trial is testing

Goal Directed Ammonia Lowering Therapy in Hyperammonemic ACLF Patients With no Overt HE to Reduce Major Adverse Liver Related Outcomes (GOAL Trial)

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 90
Not applicableStudy completedNCT07175688
What this trial is testing

Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients

Who this might be right for
Metabolic Associated Fatty Liver DiseasePancreatic SteatosisObese+2 more
Tanta University 217
Large-scale testing (Phase 3)Study completedNCT01513941
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Chronic Hepatitis C
Janssen-Cilag International NV 163
Testing effectiveness (Phase 2)Study completedNCT00771446
What this trial is testing

Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency

Who this might be right for
Acute HepatitisChronic Hepatitis
Vital Therapies, Inc. 18
Not applicableActive Not RecruitingNCT03777969
What this trial is testing

Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Beijing Friendship Hospital 2,000
Not applicableStudy completedNCT06573190
What this trial is testing

Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis BHepatic Steatosis
Yaşar Bayındır, MD 70
Post-approval studies (Phase 4)Study completedNCT00881582
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients

Who this might be right for
Chronic Hepatitis CRenal Transplant
King Abdulaziz Medical City 32
Early research (Phase 1)Study completedNCT01438320
What this trial is testing

Q-Trial in Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of California, Los Angeles 34
Post-approval studies (Phase 4)Study completedNCT00087568
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 57
Testing effectiveness (Phase 2)Study completedNCT05532124
What this trial is testing

Part A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses. Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups.

Who this might be right for
Chronic Liver Disease
Green Cross Wellbeing 49
Not applicableStudy completedNCT04546360
What this trial is testing

Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

Who this might be right for
Compensated Advanced Chronic Liver DiseaseVariceal Hemorrhage
Hepatopancreatobiliary Surgery Institute of Gansu Province 381
Post-approval studies (Phase 4)Ended earlyNCT01005238
What this trial is testing

Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine

Who this might be right for
Hepatitis, Chronic
University Hospital, Basel, Switzerland 27
Not applicableStudy completedNCT05568576
What this trial is testing

Metabolic Syndrome and Long-term Survival Following Liver Resection

Who this might be right for
Survival
Assiut University 70
Early research (Phase 1)WithdrawnNCT00255359
What this trial is testing

Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers

Who this might be right for
Chronic Hepatitis C Virus Infection
Hadassah Medical Organization 60
Early research (Phase 1)Study completedNCT02952924
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 192
Next Page